- Home
- BLTE vs NTB Comparison
BLTE vs NTB Comparison
Compare BLTE & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- NTB
- Stock Information
- Founded
- BLTE 2018
- NTB 1858
- Country
- BLTE United States
- NTB Bermuda
- Employees
- BLTE N/A
- NTB N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- NTB Commercial Banks
- Sector
- BLTE Health Care
- NTB Finance
- Exchange
- BLTE Nasdaq
- NTB Nasdaq
- Market Cap
- BLTE 2.1B
- NTB 1.9B
- IPO Year
- BLTE 2022
- NTB 2016
- Fundamental
- Price
- BLTE $68.01
- NTB $44.73
- Analyst Decision
- BLTE Strong Buy
- NTB Buy
- Analyst Count
- BLTE 4
- NTB 3
- Target Price
- BLTE $96.67
- NTB $51.33
- AVG Volume (30 Days)
- BLTE 45.0K
- NTB 184.7K
- Earning Date
- BLTE 08-11-2025
- NTB 07-28-2025
- Dividend Yield
- BLTE N/A
- NTB 4.47%
- EPS Growth
- BLTE N/A
- NTB 14.60
- EPS
- BLTE N/A
- NTB 4.96
- Revenue
- BLTE N/A
- NTB $588,897,000.00
- Revenue This Year
- BLTE N/A
- NTB $3.65
- Revenue Next Year
- BLTE N/A
- NTB $0.07
- P/E Ratio
- BLTE N/A
- NTB $9.14
- Revenue Growth
- BLTE N/A
- NTB 2.95
- 52 Week Low
- BLTE $43.70
- NTB $34.60
- 52 Week High
- BLTE $86.53
- NTB $46.89
- Technical
- Relative Strength Index (RSI)
- BLTE 59.16
- NTB 48.62
- Support Level
- BLTE $68.99
- NTB $44.58
- Resistance Level
- BLTE $74.49
- NTB $46.12
- Average True Range (ATR)
- BLTE 3.27
- NTB 0.83
- MACD
- BLTE 0.48
- NTB -0.08
- Stochastic Oscillator
- BLTE 61.59
- NTB 35.76
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.